Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Europe Throat Lozenges Market: By Product, By Application, By Flavour, By Distribution Channel and Country 2020-2031
Europe Throat Lozenges Market size was valued at approximately US$ 1,180 million in 2024 and is projected to reach about US$ 1,580 million by 2031, expanding at a CAGR of 4.2% during the forecast period (2025–2031). Moreover, the market is expected to grow significantly, reaching an estimated value of US$ 520 million by 2031, driven by seasonal demand, rising health awareness, and growing preference for over the counter (OTC) remedies.
The European throat lozenges market is also rapidly changing because of seasonally changing health patterns, the trend of self-medication, and changing consumer attitudes towards herbal and sugar-free products. As among the leading cold-related complaints, sore throat and minor pain in throat are among the most prevalent ones, lozenges have emerged as an over-the-counter first-line therapy across various age groups. Dependent upon an increasingly large population at advanced ages, one and with high incidence of respiratory infection and growing city smog, is increasingly a mandatory moving force. No more. Today's customer demands not only symptom relief but also additional value such as immune support or a clean breath. These evolving consumer demands are driving manufacturers away from conventional product forms using menthol and into the arena of experimentation with blends of zinc, honey, and plant-derived active ingredients.
At the same time, the marketplace is being re-defined by trends in overall health and expansion in e-commerce. Europe's regulatory environment permits both pharmaceutical-grade and nutraceutical lozenges to coexist, providing consumers a broad range of options from medicated to holistic, naturally occurring relief. Germany, the UK, and France are the primary markets, driven by robust OTC culture and extensive pharmacy convenience. At the same time, e-commerce sites and healthcare-focused retail chains are becoming forces for diversified distribution and product discovery. While seasonal flu trends grow in unpredictability and health consciousness reaches record levels, throat lozenges are being transformed from reactive treatment to proactive wellness solutions.
Based on product
Hard candy lozenges are at the head of the product market throughout Europe due to their long-lasting effect and popularity among customers. They dissolve slowly, maintaining active ingredients in the throat for an extended period of time and long-lasting relief from irritation or cough. They also possess a stable composition, hence are good for mass production and large-scale distribution, and possess long shelf life and minimal packaging requirements. Additionally, hard lozenges often double as breath fresheners, further making them favorites over their therapeutic uses. In the UK and Germany, in particular, hard lozenges with menthol, eucalyptus, or honey centers are especially popular during cold seasons. Their dual role, providing relief and comfort, continues to support their popularity on both OTC and well-being shelves.
Based on the application
Among all the applications, ease of sore throat is still the primary reason for lozenge usage in Europe. Cold climate, air pollution, and flu epidemics during seasons being common, consumers prefer quick and easy-to-access solutions which do not require a prescription. Lozenges for sore throat relieve sore throats using menthol, honey, and benzocaine-like compounds, which appeal to every age group, especially working individuals and the elderly. Lozenges' soothing familiarity and ease of use, combined with the immediate relief, make them a trusty first line of defense. Also, their retail pharmacy OTC status fosters self-medication tendencies, further establishing their image as a necessary home remedy for cold and allergy seasons
Based on the flavour
Menthol remains the most favored flavor among European throat lozenges due to its instant cooling and soothing feature. Widely associated with decongestion and breath freshness, menthol appeals to functional and sensate consumer needs. Menthol's strong, refreshing personality suits both wellness- and medicated-positioned lozenges. The taste also adds to the perception of efficacy, making it a popular choice among older adults and frequent users. Most flagship brands use menthol as a starting point to mix with other herbal or fruity flavors, maximizing its versatility in product creation. In cold climates and urban areas with high pollution, menthol lozenges are particularly sought after for everyday throat relief.
Based on the distribution channel
Retail pharmacies are the most significant distribution channel for throat lozenges in Europe, as they provide both credibility and convenience. Patients view pharmacies as trustworthy sources of information when searching for symptom-specific relief like lozenges for cough or sore throat. Convenience of receiving pharmacist guidance at point of sale reinforces consumer trust in product selection. Pharmacies also stock prescription-strength and OTC lozenges, offering a broad range of need. In chains and independent drug stores in countries such as France and Germany, these operators are deeply embedded in the day-to-day consumption patterns, especially when cold and flu season intensifies. They constitute the pillar of lozenge sales within the region as a result of their role in fuelling seasonal and health-related purchases.
Demand for lozenges in Europe is progressively sustained through the prevalence of seasonal diseases, allergies, and increasing self-maintenance wellness awareness. Cold and flu symptomology like sore throats, cough, and throat soreness remain the main drivers for lozenge use. Besides, aging and rising pollution levels in urban lifestyles are causing long-term throat soreness, further driving market demand. The Italian, British, and German high-over-the-counter culture allows for speedy availability, but pharmacies are the locations of trust where dispensing occurs. Brands are also gaining traction from consumers demanding lozenges as a standard line of preventive care, not incidental medication, particularly those offering immunostimulant ingredients such as echinacea, zinc, and vitamin C.
Although the market is in place, some restraints are slowing its full growth potential. Consumer confusion of throat lozenge functional positioning, symptomatic, medicated, or wellness-based, and brand-switching and eroded brand loyalty as a result are among the biggest challenges. Regulatory differences across EU member states for ingredient classification and marketing claim also add compliance complexity, especially for cross-border trade. In addition, the category is also at risk from other therapies like sprays, teas, and botanicals that are seen as more natural by health-conscious consumers. Price consciousness and the generically accepted nature of many formulas render premium differentiation difficult. Such issues are particularly acute with young cohorts who might see throat lozenges as archaic unless reformulated for broad, contemporary benefits.
Shifting the European health and well-being scene offers considerable scope for throat lozenge brands to reposition and re-invent their brands. Increased demand for vegan, sugar-free, and organic products from consumers looking after their health, and particularly consumers having dietary conditions such as diabetes or consumers looking for chemical-free alternatives, is on the anvil. Growth of direct-to-consumer (DTC) models and subscription personal health also offers opportunities for niche targeting and brand stickiness. Growing demand for multi-functional lozenges that include throat comfort in conjunction with immune function, breath freshening, or mood enhancement offers opportunities for cross-function innovation. With increased use of herbal remedy and botanical health, those brands who utilize locally applicable ingredients like thyme, sage, or elderberry can achieve significant differentiation in an otherwise sea-of-sameness OTC environment.
The most common trend of the European market for throat lozenges may be the stronger consumer appeal for herbal and naturally sourced ingredients. Shoppers today, particularly millennials and Gen Z, are gravitating toward open ingredients and steering clear of artificial sweeteners, colours, and pharmaceutical additives whenever they can. This has created an opportunity for lozenges that are honey, propolis, licorice root, echinacea, and essential oil-based that are both effective and empathetic. These types of products are viewed as safer for ongoing or daily use and meet the wellness-oriented character of this area. Firms that provide sustainability via sourcing and green packaging are on the rise, with consumers increasingly viewing product buys as a reflection of their health and environmental values, rather than merely symptom-relief devices.
Report Benchmarks |
Details |
Market Size in 2024 |
US$ 1,180 million |
Market Size in 2031 |
US$ 1,580 million |
By Application |
|
By Flavour |
|
By Distribution Channel |
|
According to PBI Analyst, the Europe Throat Lozenges Market is undergoing a transformation driven by shifting consumer preferences toward natural, sugar-free, and multifunctional remedies. Sore throat relief remains the dominant use-case, but modern consumers now seek additional benefits like immune support and breath freshness. The market is seasonally strong, particularly in colder countries, and thrives due to Europe's OTC culture and pharmacy trust. Hard candy lozenges and menthol Flavors continue to dominate shelves, while e-commerce and sustainable packaging are reshaping how consumers discover and evaluate brands. With growing demand for vegan, herbal, and clean-label products, companies that offer wellness-aligned, symptom-relieving solutions are best positioned to lead this evolving category.
Download Free Sample Report
Europe Throat Lozenges Market size was valued at approximately US$ 1,180 million in 2024 and is projected to reach about US$ 1,580 million by 2031, expanding at a CAGR of 4.2% during the forecast period (2025–2031).
Rising seasonal flu, self-medication habits, aging population, pollution-related throat issues, and growing preference for preventive wellness are driving demand.
The market is trending toward herbal, vegan, sugar-free products with functional ingredients like zinc, honey, and echinacea, along with eco-friendly packaging.
1.Executive Summary |
2.Europe Throat Lozenges Market Introduction |
2.1.Europe Throat Lozenges Market - Taxonomy |
2.2.Europe Throat Lozenges Market - Definitions |
2.2.1.Flavour |
2.2.2.Application |
2.2.3.Distribution Channel |
2.2.4.Country |
3.Europe Throat Lozenges Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Europe Throat Lozenges Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Europe Throat Lozenges Market By Flavour, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
5.1. Strawberry |
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Lemon |
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Ginger |
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Orange |
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Menthol |
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Others |
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6.Europe Throat Lozenges Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
6.1. Nicotine Replacement |
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Soar Throat |
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Cold & Cough |
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Vitamin Supplement |
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Europe Throat Lozenges Market By Distribution Channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
7.1. Hospital Pharmacies |
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Retail Pharmacies |
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Europe Throat Lozenges Market By Country, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
8.1. Germany |
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. France |
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Italy |
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. United Kingdom (UK) |
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Spain |
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.Germany Europe Throat Lozenges Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
9.1. Flavour Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Strawberry |
9.1.2.Lemon |
9.1.3.Ginger |
9.1.4.Orange |
9.1.5.Menthol |
9.1.6.Others |
9.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Nicotine Replacement |
9.2.2.Soar Throat |
9.2.3.Cold & Cough |
9.2.4.Vitamin Supplement |
9.2.5.Others |
9.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital Pharmacies |
9.3.2.Retail Pharmacies |
9.3.3.Others |
10.France Europe Throat Lozenges Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
10.1. Flavour Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Strawberry |
10.1.2.Lemon |
10.1.3.Ginger |
10.1.4.Orange |
10.1.5.Menthol |
10.1.6.Others |
10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Nicotine Replacement |
10.2.2.Soar Throat |
10.2.3.Cold & Cough |
10.2.4.Vitamin Supplement |
10.2.5.Others |
10.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital Pharmacies |
10.3.2.Retail Pharmacies |
10.3.3.Others |
11.Italy Europe Throat Lozenges Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
11.1. Flavour Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Strawberry |
11.1.2.Lemon |
11.1.3.Ginger |
11.1.4.Orange |
11.1.5.Menthol |
11.1.6.Others |
11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Nicotine Replacement |
11.2.2.Soar Throat |
11.2.3.Cold & Cough |
11.2.4.Vitamin Supplement |
11.2.5.Others |
11.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital Pharmacies |
11.3.2.Retail Pharmacies |
11.3.3.Others |
12.United Kingdom (UK) Europe Throat Lozenges Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
12.1. Flavour Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Strawberry |
12.1.2.Lemon |
12.1.3.Ginger |
12.1.4.Orange |
12.1.5.Menthol |
12.1.6.Others |
12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Nicotine Replacement |
12.2.2.Soar Throat |
12.2.3.Cold & Cough |
12.2.4.Vitamin Supplement |
12.2.5.Others |
12.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital Pharmacies |
12.3.2.Retail Pharmacies |
12.3.3.Others |
13.Spain Europe Throat Lozenges Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
13.1. Flavour Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Strawberry |
13.1.2.Lemon |
13.1.3.Ginger |
13.1.4.Orange |
13.1.5.Menthol |
13.1.6.Others |
13.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Nicotine Replacement |
13.2.2.Soar Throat |
13.2.3.Cold & Cough |
13.2.4.Vitamin Supplement |
13.2.5.Others |
13.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital Pharmacies |
13.3.2.Retail Pharmacies |
13.3.3.Others |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Pfizer |
14.2.2.Procter & Gamble (P&G) |
14.2.3.GlaxoSmithKline Pharmaceuticals Limited |
14.2.4.Bliss GVS Pharma Ltd. |
14.2.5.Thornton & Ross |
14.2.6.Crown Confectionery Co. Ltd. |
14.2.7.CRM Group |
14.2.8.United confections |
14.2.9.August Storck KG |
14.2.10.Roshen Confectionery Corp |
14.2.11.United Confections Throat lozenge |
14.2.12.Prestige Consumer Healthcare, Inc. |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players